Hypothyroidism does affect fertility, and it does so through multiple pathways. Thyroid hormones play a direct role in ovarian function, hormone balance, and the ability to sustain a pregnancy. The good news is that thyroid-related fertility problems are among the most treatable causes of difficulty conceiving, often improving within weeks of starting treatment.
How Thyroid Hormones Influence Reproduction
Thyroid hormones aren’t just about metabolism. They act directly on the ovaries, uterus, and uterine lining. In the ovaries, they stimulate the growth and survival of granulosa cells, the cells that surround and nourish developing eggs. They do this partly by amplifying your body’s response to follicle-stimulating hormone (FSH), the key hormone that drives egg maturation each cycle. When thyroid levels drop, your ovaries become less responsive to FSH, which can slow or stall follicle development.
Animal studies show the consequences clearly: hypothyroid rats have fewer developing follicles and faster breakdown of the follicles they do produce. Thyroid hormones also support the process that prepares the uterine lining for implantation, a step called decidualization. Without adequate thyroid function, the lining may not develop properly, making it harder for a fertilized egg to attach and grow.
The Prolactin Connection
One of the most disruptive effects of hypothyroidism on fertility happens through a hormone most people associate with breastfeeding: prolactin. When your thyroid is underactive, your brain compensates by releasing more thyrotropin-releasing hormone (TRH) to try to stimulate the thyroid. But TRH doesn’t just trigger thyroid-stimulating hormone. It also triggers prolactin release from the pituitary gland.
Elevated prolactin interferes with the pulsing release of gonadotropin-releasing hormone (GnRH), which is the master signal that drives your entire menstrual cycle. The result depends on how high prolactin climbs. Mildly elevated levels can cause a weak corpus luteum that doesn’t produce enough progesterone. Higher levels can cause irregular periods, and very high levels can stop ovulation entirely. Some women also notice unexpected breast discharge, a condition called galactorrhea, which is a telltale sign of this hormonal chain reaction. Infertile women with hypothyroidism have significantly higher prolactin levels compared to women with normal thyroid function.
Effects on Progesterone and the Luteal Phase
Even if ovulation still occurs, hypothyroidism can undermine what happens next. After ovulation, the empty follicle transforms into the corpus luteum, which produces progesterone to sustain the uterine lining during the critical window when an embryo would implant. Thyroid hormones are directly involved in progesterone and estradiol production, and low levels can lead to a shortened or inadequate luteal phase.
Research has confirmed that total T4 levels are positively associated with progesterone during the luteal phase and estrogen during the follicular phase. A short or weak luteal phase means the uterine lining may begin breaking down before an embryo has time to implant, or shortly after. This can look like very early pregnancy loss, sometimes before a woman even realizes she conceived. Hypothyroidism is also generally associated with heavier menstrual bleeding and more frequent periods, both signs that hormonal timing is off.
Miscarriage Risk With Elevated TSH
Even once pregnancy is achieved, hypothyroidism raises the risk of early loss. A large nested case-control study found that women with first-trimester TSH levels between 2.5 and 4.87 mIU/L had a 47% higher odds of miscarriage compared to women with TSH in the 0.4 to 2.5 range. For women with TSH above 4.87 mIU/L, the risk roughly doubled.
What makes this particularly important is that these elevated risks appeared even in women who tested negative for thyroid antibodies, suggesting the TSH elevation itself contributes to pregnancy loss, not just the autoimmune process that often causes hypothyroidism. The risk was actually slightly higher in antibody-negative women with very elevated TSH, with 2.5 times the odds of miscarriage compared to those with optimal levels.
Thyroid Antibodies Matter Too
Many cases of hypothyroidism are caused by Hashimoto’s thyroiditis, an autoimmune condition where the body produces antibodies against the thyroid, most commonly thyroid peroxidase antibodies (TPO antibodies). These antibodies appear to affect fertility independently of TSH levels. Women who test positive for TPO antibodies tend to have higher TSH, but even those with normal TSH and positive antibodies face a higher rate of miscarriage and increased difficulty conceiving.
After adjusting for age and TSH levels, antibody positivity remains an independent risk factor for pregnancy loss. Some research also suggests women with these antibodies have poorer outcomes with IVF, even when their thyroid numbers look normal on paper. This is why many fertility specialists test for thyroid antibodies as part of a workup, not just TSH alone.
Hypothyroidism and Male Fertility
This isn’t only a concern for women. Hypothyroidism in men adversely affects semen quality, reducing semen volume and progressive sperm motility (the ability of sperm to swim forward effectively). Studies have also reported abnormal sperm shape in hypothyroid men. While male thyroid disorders get far less attention in fertility discussions, they can meaningfully contribute to a couple’s difficulty conceiving.
TSH Targets for Women Trying to Conceive
The standard definition of subclinical hypothyroidism is a TSH above 4.5 to 5.0 mIU/L with normal free T4. But in the context of fertility, many clinicians aim for tighter control. The miscarriage data showing increased risk at TSH levels above 2.5 mIU/L has shaped how many reproductive endocrinologists approach treatment, even though universal thyroid screening for all women trying to conceive is not formally recommended by major guidelines.
The American Society for Reproductive Medicine recommends what it calls “aggressive case finding,” meaning TSH testing for women with risk factors: autoimmune conditions, family history of thyroid disease, prior thyroid problems or surgery, history of neck radiation, or symptoms of thyroid dysfunction. If you’re struggling with fertility, asking for a thyroid panel that includes TSH, free T4, and TPO antibodies is reasonable, especially since the fix is straightforward.
How Quickly Treatment Works
Thyroid replacement therapy is one of the fastest-acting interventions in reproductive medicine. In fertility treatment protocols, women typically start thyroid medication one to four weeks before beginning assisted reproduction, and this is sufficient to see improvement. Clinical protocols commonly use a starting dose adjusted to body weight, taken each morning.
Once TSH reaches the target range, the downstream hormonal effects begin to normalize: prolactin drops, GnRH pulsing recovers, progesterone output from the corpus luteum improves, and menstrual cycle regularity often returns. For women whose primary barrier to conception was undiagnosed or undertreated hypothyroidism, restoring normal thyroid function can make the difference between months of unexplained infertility and a successful pregnancy. Treatment is typically continued throughout pregnancy, since thyroid hormone demands increase significantly as the pregnancy progresses.